Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma

Tian-You Chen; Zong-Guo Yang; Ying Li; Mao-Quan Li

doi:10.4329/wjr.v15.i4.89

Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma

World J Radiol. 2023 Apr 28;15(4):89-97. doi: 10.4329/wjr.v15.i4.89.

Authors

Tian-You Chen¹, Zong-Guo Yang², Ying Li³, Mao-Quan Li⁴

Affiliations

¹ Department of Interventional Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
² Department of Integrative Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
³ Department of Radiology, Jinshan Hospital, Fudan University, Shanghai 201508, China.
⁴ Department of Interventional & Vascular Surgery, Tenth People's Hospital of Tongji University, Tongji University, Shanghai 200433, China. cjr.limaoquan@vip.163.com.

Abstract

Radiomics is a hot topic in the research on customized oncology treatment, efficacy evaluation, and tumor prognosis prediction. To achieve the goal of mining the heterogeneity information within the tumor tissue, the image features concealed within the tumoral images are turned into quantifiable data features. This article primarily describes the research progress of radiomics and clinical-radiomics combined model in the prediction of efficacy, the choice of treatment modality, and survival in transarterial chemoembolization (TACE) and TACE combination therapy for hepatocellular carcinoma.

Keywords: Computed tomography; Hepatocellular carcinoma; Magnetic resonance imaging; Radiomics; Transarterial chemoembolization.

Publication types

Review